Answers are grounded in this paper and cite their sources.
Airway complications remain a critical source of morbidity and mortality after lung transplantation, and bronchial stenosis is the most frequent. Mitomycin C, an antineoplastic agent that inhibits fibroblast proliferation, has been applied topically in the upper airway and trachea. On the basis of our experience of treating tracheal stenosis with mitomycin C, this technique has been employed with the objective of preventing restenosis in pulmonary transplant patients. We report, what we believe to be the first 2 cases of patients successfully treated with topical mitomycin C for recurrent bronchial stenosis after lung transplantation.
No takes yet. Share an insight, caveat, or question.
Cosano-Povedano et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: